Kate Nicholson

1.0k total citations · 1 hit paper
9 papers, 667 citations indexed

About

Kate Nicholson is a scholar working on Cellular and Molecular Neuroscience, Surgery and Pharmacology. According to data from OpenAlex, Kate Nicholson has authored 9 papers receiving a total of 667 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Cellular and Molecular Neuroscience, 2 papers in Surgery and 2 papers in Pharmacology. Recurrent topics in Kate Nicholson's work include Neuroscience and Neuropharmacology Research (3 papers), Estrogen and related hormone effects (2 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). Kate Nicholson is often cited by papers focused on Neuroscience and Neuropharmacology Research (3 papers), Estrogen and related hormone effects (2 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). Kate Nicholson collaborates with scholars based in United States, Canada and Italy. Kate Nicholson's co-authors include Jordi Bruix, Josep M. Llovet, Jiamei Yang, Won Young Tak, Guohong Han, Riccardo Lencioni, Gerold Meinhardt, Seung Woon Paik, L Ruíz del Arbol and Angelo Luca and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neuroscience and Journal of Hepatology.

In The Last Decade

Kate Nicholson

8 papers receiving 653 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial

2016 479 citations Riccardo Lencioni, Josep M. Llovet et al. Journal of Hepatology profile →

Peers

Countries citing papers authored by Kate Nicholson

Since Specialization

Citations

This map shows the geographic impact of Kate Nicholson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kate Nicholson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kate Nicholson more than expected).

Fields of papers citing papers by Kate Nicholson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kate Nicholson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kate Nicholson. The network helps show where Kate Nicholson may publish in the future.

Co-authorship network of co-authors of Kate Nicholson

This figure shows the co-authorship network connecting the top 25 collaborators of Kate Nicholson. A scholar is included among the top collaborators of Kate Nicholson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kate Nicholson. Kate Nicholson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Cannabidiol (CBD) potentiates physiological and behavioral markers of hypothalamic–pituitary–adrenal (HPA) axis responsivity in female and male mice 2025 ·Psychopharmacology ·(unknown), (unknown), Kate Nicholson, Amy E. M. Newman, Jibran Y. Khokhar	2
2	Lessons learned from the INTEGRATE-Pain Delphi process to develop core outcome sets (COS) across the pain continuum 2025 ·Pain Medicine ·(unknown), Janelle E. Letzen, (unknown), Judy Birch, Anthony F. Domenichiello, Ulrike Kaiser, Kate Nicholson, Daniela C. Rosenberger, Laura D. Wandner, Esther Pogatzki‐Zahn	1
3	The Lysine Acetyltransferase PCAF Functionally Interacts with Estrogen Receptor Alpha in the Hippocampus of Gonadally Intact Male—But Not Female—Rats to Enhance Short-Term Memory 2024 ·Journal of Neuroscience ·(unknown), Kate Nicholson, (unknown), (unknown), (unknown), Samantha D. Creighton, (unknown), Ciro Milite, Sabrina Castellano, Gianluca Sbardella, Neil J. MacLusky, Elena Choleris, Boyer D. Winters	0
4	ASRA Pain Medicine consensus guidelines on the management of the perioperative patient on cannabis and cannabinoids 2023 ·Regional Anesthesia & Pain Medicine ·Shalini Shah, Eric S. Schwenk, Rakesh V. Sondekoppam, Hance Clarke, Mark Zakowski, (unknown), (unknown), Kate Nicholson, Gary Schwartz, W. Michael Hooten, Mark S. Wallace, Eugene R. Viscusi, Samer Narouze	38
5	Androgen Effects on Neural Plasticity 2021 ·PubMed ·(unknown), Kate Nicholson, (unknown), Neil J. MacLusky	17
6	Synaptic effects of estrogen 2020 ·Vitamins and hormones ·Kate Nicholson, Neil J. MacLusky, Csaba Leranth	7
7	Elevated AT1R Antibody and Morbidity in Patients Bridged to Heart Transplant Using Continuous Flow Left Ventricular Assist Devices 2020 ·Journal of Cardiac Failure ·Vinh Q. Chau, Maureen Flattery, Kate Nicholson, (unknown), Gaurav Gupta, Patricia A. Uber, Anna Priday, (unknown), Pamela Kimball, Keyur B. Shah	8
8	Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial breakdown → 2016 ·Journal of Hepatology ·Riccardo Lencioni, Josep M. Llovet, Guohong Han, Won Young Tak, Jiamei Yang, Alfredo Guglielmi, Seung Woon Paik, María Reig, Do Young Kim, Gar-Yang Chau, Angelo Luca, L Ruíz del Arbol, (unknown), (unknown), Kate Nicholson, Gerold Meinhardt, Jordi Bruix	479
9	Sorafenib or placebo in combination with transarterial chemoembolization (TACE) with doxorubicin-eluting beads (DEBDOX) for intermediate-stage hepatocellular carcinoma (HCC): Phase II, randomized, double-blind SPACE trial. 2012 ·Journal of Clinical Oncology ·Riccardo Lencioni, Josep M. Llovet, Guohong Han, Won Young Tak, Jiamei Yang, (unknown), (unknown), Kate Nicholson, Gerold Meinhardt, Jordi Bruix	115

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact